OTCPK:COSM

Stock Analysis Report

Executive Summary

Cosmos Holdings Inc., through its subsidiaries, operates as a pharmaceutical wholesaler primarily in the European Union.

Snowflake

Fundamentals

Worrying balance sheet with weak fundamentals.

Risks

  • Cosmos Holdings has significant price volatility in the past 3 months.
  • Cosmos Holdings is not covered by any analysts.

Share Price & News

How has Cosmos Holdings's share price performed over time and what events caused price changes?


Latest Share Price and Events


Market Performance


7 Day Return

5.4%

OTCPK:COSM

0.1%

US Healthcare

0.8%

US Market


1 Year Return

-48.3%

OTCPK:COSM

-8.4%

US Healthcare

1.9%

US Market

COSM underperformed the Healthcare industry which returned -7.7% over the past year.

COSM underperformed the Market in United States of America which returned 2.1% over the past year.


Share holder returns

COSMIndustryMarket
7 Day5.4%0.1%0.8%
30 Day9.2%-1.4%3.4%
90 Day-29.7%-0.7%2.1%
1 Year-48.3%-48.3%-7.0%-8.4%4.2%1.9%
3 Year-54.3%-54.3%30.6%25.3%46.7%37.2%
5 Year-70.2%-70.2%64.9%55.1%62.3%44.5%

Price Volatility Vs. Market

How volatile is Cosmos Holdings's share price compared to the market and industry in the last 5 years?


Simply Wall St News

No news available

Valuation

Is Cosmos Holdings undervalued based on future cash flows and its price relative to the stock market?


In this section, we usually try to help investors determine whether Cosmos Holdings is trading at an attractive price based on the cash flow it is expected to produce in the future. But as Cosmos Holdings has not provided consistent financial data, and the stock also has no analyst forecast or coverage, its intrinsic value cannot be reliably calculated by extrapolating past data or using analyst consensus cash flow predictions.

This is quite a rare situation as 89% of companies covered by Simply Wall St do have a valuation analysis.


Next Steps

  • Take a look at our analysis of COSM’s management and see if the CEO’s compensation is within a reasonable range, who is on the board and if insiders have been trading lately.
  • When valuing a company like this, investors focus more on how they perceive the size of the opportunity, the company's ability to deliver and scale, and the strength of the team. While we are not analysing this type of data at the moment, if you don’t know where to start, we recommend reading through Cosmos Holdings regulatory filings here.
  • Explore potentially undervalued companies in the Healthcare industry.

Future Growth

How is Cosmos Holdings expected to perform in the next 1 to 3 years based on estimates from 0 analysts?

10.9%

Forecasted Healthcare industry annual growth in earnings


In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Cosmos Holdings has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Next Steps

  • Take a look at our analysis of COSM’s management and see if the CEO’s compensation is within a reasonable range, who is on the board and if insiders have been trading lately.
  • While we do not consider unaudited financials to be a reliable enough to include in our analysis, you can access them on the OTC Markets Website. If you are looking for more of a qualitative research into the company, you can access Cosmos Holdings's filings and announcements here.
  • Explore growth companies in the Healthcare industry.

Past Performance

How has Cosmos Holdings performed over the past 5 years?

-48.1%

Historical annual earnings growth


Earnings and Revenue History


Past Earnings Growth Analysis

Cosmos Holdings does not make a profit and their year on year earnings growth rate was negative over the past 5 years.

Unable to compare Cosmos Holdings's 1-year earnings growth to the 5-year average as it is not currently profitable.

Unable to compare Cosmos Holdings's 1-year growth to the US Healthcare industry average as it is not currently profitable.


Return on Equity

It is difficult to establish if Cosmos Holdings has efficiently used shareholders’ funds last year (Return on Equity greater than 20%) due to its liabilities exceeding its assets.


Return on Assets

It is difficult to establish if Cosmos Holdings has efficiently used its assets last year compared to the US Healthcare industry average (Return on Assets) as it is loss-making.


Return on Capital Employed

It is difficult to establish if Cosmos Holdings improved its use of capital last year versus 3 years ago (Return on Capital Employed) due to its liabilities exceeding its assets.


Next Steps

Financial Health

How is Cosmos Holdings's financial position?


Financial Position Analysis

Cosmos Holdings's short term (1 year) commitments are greater than its holdings of cash and other short term assets.

Cosmos Holdings's cash and other short term assets cover its long term commitments.


Debt to Equity History and Analysis

Cosmos Holdings has negative shareholder equity (liabilities exceed assets), this is a more serious situation compared with a high debt level.

Irrelevant to check if Cosmos Holdings's debt level has increased considering it has negative shareholder equity.


Balance Sheet

High level of physical assets or inventory.

Cosmos Holdings has negative shareholder equity (liabilities exceed assets) therefore debt is not covered by short term assets.


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Cosmos Holdings has less than a year of cash runway based on current free cash flow.

Cosmos Holdings has less than a year of cash runway if free cash flow continues to grow at historical rates of 17.1% each year.


Next Steps

Dividend

What is Cosmos Holdings's current dividend yield, its reliability and sustainability?


Dividend Yield and Payments Analysis

Unable to evaluate Cosmos Holdings's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.

Unable to evaluate Cosmos Holdings's dividend against the top 25% market benchmark as the company has not reported any payouts.

Unable to perform a dividend volatility check as Cosmos Holdings has not reported any payouts.

Unable to verify if Cosmos Holdings's dividend has been increasing as the company has not reported any payouts.


Current Payout to Shareholders

Unable to calculate sustainability of dividends as Cosmos Holdings has not reported any payouts.


Future Payout to Shareholders

Insufficient estimate data to determine if a dividend will be paid in 3 years and that it will be sustainable.


Next Steps

Management

What is the CEO of Cosmos Holdings's salary, the management and board of directors tenure and is there insider trading?

2.8yrs

Average board tenure


CEO

Greg Siokas (54yo)

3.6yrs

Tenure

0

Mr. Grigorios Siokas, also known as Greg, has been Chairman, Chief Executive Officer and Chief Financial Officer of Cosmos Holdings Inc. since February 26, 2016 and served as its President since December 0 ...


Board Age and Tenure

2.8yrs

Average Tenure

53.5yo

Average Age

The average tenure for the Cosmos Holdings board of directors is less than 3 years, this suggests a new board.


Insider Trading

More shares have been bought than sold by Cosmos Holdings individual insiders in the past 3 months.


Recent Insider Transactions

SellUS$25,49806 Sep 19
Grigorios Siokas
EntityIndividual
Role
Chief Executive Officer
Chairman
Shares34,666
Max PriceUS$3.30
BuyUS$550,00526 Jun 19
Grigorios Siokas
EntityIndividual
Role
Chief Executive Officer
Chairman
Shares73,334
Max PriceUS$7.50
SellUS$123,91618 Jun 19
Grigorios Siokas
EntityIndividual
Role
Chief Executive Officer
Chairman
Shares30,000
Max PriceUS$4.50
BuyUS$500,00328 May 19
Grigorios Siokas
EntityIndividual
Role
Chief Executive Officer
Chairman
Shares66,667
Max PriceUS$7.50
SellUS$500,00028 May 19
Grigorios Siokas
EntityIndividual
Role
Chief Executive Officer
Chairman
Shares200,000
Max PriceUS$2.50
SellUS$114,54427 Feb 19
Grigorios Siokas
EntityIndividual
Role
Chief Executive Officer
Chairman
Shares37,400
Max PriceUS$4.20
SellUS$1,781,18021 Dec 18
Grigorios Siokas
EntityIndividual
Role
Chief Executive Officer
Chairman
Shares544,300
Max PriceUS$4.48
SellUS$331,88501 Nov 18
Grigorios Siokas
EntityIndividual
Role
Chief Executive Officer
Chairman
Shares191,775
Max PriceUS$4.56
SellUS$285,34429 Oct 18
Grigorios Siokas
EntityIndividual
Role
Chief Executive Officer
Chairman
Shares71,875
Max PriceUS$3.97

Ownership Breakdown


Management Team

  • Demetrios Demetriades (53yo)

    Secretary & Director

    • Tenure: 5.7yrs
  • Greg Siokas (54yo)

    Chairman

    • Tenure: 3.6yrs

Board Members

  • Anastasios Tzikas

    Member of Advisory Board

    • Tenure: 0.8yrs
  • Tom Kolefas

    Member of Advisory Board

    • Tenure: 0.7yrs
  • Dimitrios Goulielmos (52yo)

    Director

    • Tenure: 6yrs
  • Demetrios Demetriades (53yo)

    Secretary & Director

    • Tenure: 5.7yrs
  • Greg Siokas (54yo)

    Chairman

    • Tenure: 3.6yrs
  • John Hoidas (54yo)

    Director

    • Tenure: 2.8yrs
  • Orestes Varvitsiotes

    Member of Advisory Board

    • Tenure: 2.7yrs

Company Information

Cosmos Holdings Inc.'s company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Cosmos Holdings Inc.
  • Ticker: COSM
  • Exchange: OTCPK
  • Founded:
  • Industry: Health Care Distributors
  • Sector: Healthcare
  • Market Cap: US$35.860m
  • Shares outstanding: 13.09m
  • Website: https://www.cosmosholdingsinc.com

Number of Employees


Location

  • Cosmos Holdings Inc.
  • 141 West Jackson Boulevard
  • Suite 4236
  • Chicago
  • Illinois
  • 60604
  • United States

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
COSMOTCPK (Pink Sheets LLC)YesCommon StockUSUSDSep 2013

Biography

Cosmos Holdings Inc., through its subsidiaries, operates as a pharmaceutical wholesaler primarily in the European Union. It imports, exports, and distributes branded pharmaceutical products, generic pharma ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2019/09/18 00:07
End of Day Share Price2019/09/17 00:00
Earnings2019/06/30
Annual Earnings2018/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.